Blazar BR - Search Results

1

In vivo administration of anti-CD3 monoclonal antibodies or immunotoxins in murine recipients of allogeneic T cell-depleted marrow for the promotion of engraftment.

Blazar BR, Hirsch R, Gress RE, Carroll SF, Vallera DA. Blazar BR, et al. J Immunol. 1991 Sep 1;147(5):1492-503. J Immunol. 1991. PMID: 1831826

2

Promotion of murine marrow alloengraftment and hematopoietic recovery across the major histocompatibility barrier by administration of recombinant human interleukin-1 alpha.

Blazar BR, Widmer MB, Taylor PA, Vallera DA. Blazar BR, et al. Blood. 1992 Sep 15;80(6):1614-22. Blood. 1992. PMID: 1369829 Free article.

3

Anti-CD3 immunotoxin prevents low-dose STZ/interferon-induced autoimmune diabetes in mouse.

Vallera DA, Carroll SF, Brief S, Blazar BR. Vallera DA, et al. Among authors: blazar br. Diabetes. 1992 Apr;41(4):457-64. doi: 10.2337/diab.41.4.457. Diabetes. 1992. PMID: 1376702

4

Effect of recombinant human macrophage colony-stimulating factor in irradiated murine recipients of T-cell-depleted allogeneic or non-depleted syngeneic bone marrow transplants.

Blazar BR, Aukerman SL, Vallera DA. Blazar BR, et al. Blood. 1992 Mar 15;79(6):1636-42. Blood. 1992. PMID: 1547353 Free article.

5

General strategies in in vivo animal modeling.

Vallera DA, Blazar BR. Vallera DA, et al. Among authors: blazar br. Targeted Diagn Ther. 1992;7:63-77. Targeted Diagn Ther. 1992. PMID: 1633310 Review. No abstract available.

6

T cell depletion with anti-CD5 immunotoxin in histocompatible bone marrow transplantation. The correlation between residual CD5 negative T cells and subsequent graft-versus-host disease.

Filipovich AH, Vallera D, McGlave P, Polich D, Gajl-Peczalska K, Haake R, Lasky L, Blazar B, Ramsay NK, Kersey J, et al. Filipovich AH, et al. Transplantation. 1990 Sep;50(3):410-5. doi: 10.1097/00007890-199009000-00011. Transplantation. 1990. PMID: 1698319

7

Prevention of murine graft-versus-host disease and bone marrow alloengraftment across the major histocompatibility barrier after donor graft preincubation with anti-LFA1 immunotoxin.

Blazar BR, Carroll SF, Vallera DA. Blazar BR, et al. Blood. 1991 Dec 1;78(11):3093-102. Blood. 1991. PMID: 1954395 Free article.

8

Pretreatment of murine donor grafts with L-leucyl-L-leucine methyl ester: elimination of graft-versus-host disease without detrimental effects on engraftment.

Blazar BR, Thiele DL, Vallera DA. Blazar BR, et al. Blood. 1990 Feb 1;75(3):798-805. Blood. 1990. PMID: 1967541 Free article.

9

Toxicity and efficacy of anti-T-cell ricin toxin A chain immunotoxins in a murine model of established graft-versus-host disease induced across the major histocompatibility barrier.

Vallera DA, Carroll SF, Snover DC, Carlson GJ, Blazar BR. Vallera DA, et al. Among authors: blazar br. Blood. 1991 Jan 1;77(1):182-94. Blood. 1991. PMID: 1984794 Free article.

10

Radiotherapy in mice with yttrium-90-labeled anti-Ly1 monoclonal antibody: therapy of the T cell lymphoma EL4.

Schmidberger H, Buchsbaum DJ, Blazar BR, Everson P, Vallera DA. Schmidberger H, et al. Among authors: blazar br. Cancer Res. 1991 Apr 1;51(7):1883-90. Cancer Res. 1991. PMID: 2004371

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

904 results

Search Page

Filters